Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munir Alam

Showing results (71-80 of 206) with videos related to

Pageof 21
Sort By:
Plos Pathogens|September 13, 2011
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodiesBen-Jiang Ma, S Munir Alam, Eden P Go, et al.
Journal of Virology|May 6, 2011
An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serumGuido Ferrari, Justin Pollara, Daniel Kozink, et al.
Journal of the American Chemical Society|August 7, 2013
Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccinesBaptiste Aussedat, Yusuf Vohra, Peter K Park, et al.
Journal of Virology|May 16, 2008
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigensMei-Yun Zhang, Bang K Vu, Anil Choudhary, et al.
Msphere|March 28, 2020
HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in InfancyAlan D Curtis, Maria Dennis, Joshua Eudailey, et al.
Nature|February 26, 2011
Programming the magnitude and persistence of antibody responses with innate immunitySudhir Pai Kasturi, Ioanna Skountzou, Randy A Albrecht, et al.
Journal of Virology|October 13, 2017
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 VaccineXiaoying Shen, Rahul Basu, Sheetal Sawant, et al.
Plos One|May 25, 2012
Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrumJames Friedman, S Munir Alam, Xiaoying Shen, et al.
Journal of Virology|December 14, 2018
Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus MacaquesMaria Dennis, Joshua Eudailey, Justin Pollara, et al.
Mabs|March 23, 2010
Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1Mei-Yun Zhang, Andrew Rosa Borges, Roger G Ptak, et al.
Pageof 21

Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
Plos Pathogens|September 13, 2011
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodiesBen-Jiang Ma, S Munir Alam, Eden P Go, et al.
Journal of Virology|May 6, 2011
An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serumGuido Ferrari, Justin Pollara, Daniel Kozink, et al.
Journal of the American Chemical Society|August 7, 2013
Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccinesBaptiste Aussedat, Yusuf Vohra, Peter K Park, et al.
Journal of Virology|May 16, 2008
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigensMei-Yun Zhang, Bang K Vu, Anil Choudhary, et al.
Msphere|March 28, 2020
HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in InfancyAlan D Curtis, Maria Dennis, Joshua Eudailey, et al.
Nature|February 26, 2011
Programming the magnitude and persistence of antibody responses with innate immunitySudhir Pai Kasturi, Ioanna Skountzou, Randy A Albrecht, et al.
Journal of Virology|October 13, 2017
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 VaccineXiaoying Shen, Rahul Basu, Sheetal Sawant, et al.
Plos One|May 25, 2012
Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrumJames Friedman, S Munir Alam, Xiaoying Shen, et al.
Journal of Virology|December 14, 2018
Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus MacaquesMaria Dennis, Joshua Eudailey, Justin Pollara, et al.
Mabs|March 23, 2010
Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1Mei-Yun Zhang, Andrew Rosa Borges, Roger G Ptak, et al.
Pageof 21